Abbott’s Xience Sierra Coronary Stent Approved in Japan

May 3, 2018

Abbott’s Xience Sierra everolimus-eluting coronary stent was granted national reimbursement by the Japanese Ministry of Health Labor and Welfare to treat coronary artery disease.

The new stent features an enhanced design, a new delivery system and unique sizes for use in challenging cases.

Xience Sierra was developed to help doctors more easily treat individuals with difficult blockages that involve multiple or completely blocked arteries or complications like diabetes.

View today's stories